Document Detail

Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome.
MedLine Citation:
PMID:  17261408     Owner:  NLM     Status:  MEDLINE    
Aortic root dilatation is the principal life-threatening complication in Marfan syndrome, leading to aortic regurgitation, dissection, and rupture. Beta blockade slows aortic dilatation in adults, but there has been no definitive evidence in children. Therefore, the evolution of aortic diameter at the level of the sinuses of Valsalva in 155 children (82 males, 73 females) aged <12 years who had been diagnosed with Marfan syndrome according to international criteria was retrospectively studied. Affected children treated by beta blockade >or=1 time during their lives (n = 77, mean age at diagnosis 6.1 +/- 3.2 years) were compared with affected children who had never received beta blockers (n = 78; 42 males, mean age 7.4 +/- 5.2 years). A mean delay of 1.3 years was observed between diagnosis and the initiation of beta blockade in the treated group (mean age at initiation 7.5 years). At the time of diagnosis, aortic diameters were similar in the 2 groups, but after 1.3 years, aortic diameters were greater in the group of children in whom beta blockers had been initiated. On univariate analysis, aortic diameter was related to age and height, but not gender or familial history of aortic dissection. On multivariate analysis, treatment and age remained significant determinants of aortic diameter. Beta blockade significantly decreased the rate of aortic dilatation at the level of the sinuses of Valsalva by a mean of 0.16 mm/year (p <0.05), an effect that increased with treatment duration. A trend toward lower cardiac mortality, decreased need for preventive aortic surgery, and less dissection was observed. In conclusion, beta blockade appears to limit aortic dilatation during childhood in patients affected by Marfan syndrome. Therefore, this treatment should be recommended as soon as the diagnosis is made.
Magalie Ladouceur; Christophe Fermanian; Jean-Marc Lupoglazoff; Thomas Edouard; Yves Dulac; Philippe Acar; Suzel Magnier; Guillaume Jondeau
Related Documents :
22672878 - Norms for imaging markers of brain reserve.
3411488 - Age and the transmittance of the human crystalline lens.
15784628 - Increased stiffness of the abdominal aorta in women with rheumatoid arthritis.
3936228 - The effect of an acute phase reaction and bcg innoculation on factor viii in the guinea...
16913208 - Accuracy of obesity diagnosis in brazilian adolescents: comparison of cole et al and mu...
7488398 - Skin thickness in patients with osteoporosis and controls quantified by ultrasound a scan.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2006-12-14
Journal Detail:
Title:  The American journal of cardiology     Volume:  99     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-30     Completed Date:  2007-03-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  406-9     Citation Subset:  AIM; IM    
Consultation Marfan, Hôpital Ambroise Paré Assistance-Publique Hopitaux de Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Aortic Diseases / drug therapy*,  etiology
Dilatation, Pathologic / drug therapy,  etiology,  ultrasonography
Follow-Up Studies
Marfan Syndrome / complications*
Retrospective Studies
Severity of Illness Index
Sinus of Valsalva*
Treatment Outcome
Reg. No./Substance:
0/Adrenergic beta-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and du...
Next Document:  Safety and efficacy of statins in Asians.